SAGE Therapeutics Inc (NASDAQ:SAGE)
| 20.58 Delayed Data As of Sep 29 |  -0.14 / -0.68%Today’s Change | 16.52 Today|||52-Week Range 59.99 | -46.04% Year-to-Date |
Largest transactions by value over
| Name | Type | Date | Shares traded | Share price | Transaction value | Since transaction |
|---|---|---|---|---|---|---|
Greene Barry E President & Chief Executive Officer |  Buy | 11/10/2022 | 14,500 | $34.48 | $500.0K | -41.30% |
Jonas Jeffrey M Director |  Sale | 2/10/2023 | 7,805 | $44.47 | $347.1K | -54.28% |
Jonas Jeffrey M Director | Sale | 2/10/2023 | 3,838 | $44.90 | $172.3K | -54.28% |
Benecchi Christopher Chief Business Officer | Sale | 2/03/2023 | 2,119 | $44.16 | $93.6K | -53.40% |
Jonas Jeffrey M Director | Buy | 1/03/2023 | 2,501 | $28.63 | $71.6K | -44.78% |
Jonas Jeffrey M Director | Sale | 2/03/2023 | 1,427 | $44.16 | $63.0K | -53.40% |
Barrett Elizabeth /pfizer/ Director | Buy | 5/09/2023 | 1,000 | $50.50 | $50.5K | -59.38% |
Robichaud Albert J Chief Scientific Officer | Sale | 2/03/2023 | 1,127 | $44.16 | $49.8K | -53.40% |
Cook Anne Marie Secretary, Senior Vice President & General Counsel | Sale | 2/03/2023 | 980 | $44.16 | $43.3K | -53.40% |
Iguchi Kimi E Chief Financial Officer & Treasurer | Sale | 2/03/2023 | 914 | $44.16 | $40.4K | -53.40% |
Page of 2